Invesco
FHTX icon

Invesco’s Foghorn Therapeutics FHTX Stock Holding History

Invesco’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$381K Buy
78,135
+60,399
+341% +$268K ﹤0.01% 3350
2026
Q1 		$84.8K Buy
17,736
+6,951
+64% +$38.2K ﹤0.01% 3644
2025
Q4 		$58.2K Buy
+10,785
New +$48.9K ﹤0.01% 3691
2024
Q2 		– Sell
-56,042
Closed -$376K – 3915
2024
Q1 		$376K Buy
+56,042
New +$311K ﹤0.01% 3452

Other funds holding FHTX

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
EC
Euclidean Capital New York $440M AUM 28.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

Invesco's FHTX Position: Q2 2026 in Review

Invesco increased its Foghorn Therapeutics (FHTX) stake by 341% in Q2 2026, buying an estimated $268K and bringing the position to 78,135 shares worth $381K. The position accounts for ﹤0.01% of the portfolio, ranked #3350.

Invesco first reported a position in FHTX in Q1 2024 and has held it in 4 quarters since. 103 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Invesco held 78,135 shares of Foghorn Therapeutics worth $381K as of Q2 2026.
  • Invesco bought 60,399 Foghorn Therapeutics shares in Q2 2026, an estimated $268K.
  • Foghorn Therapeutics made up ﹤0.01% of Invesco's portfolio in Q2 2026, its #3350 holding.
  • Invesco first reported a position in Foghorn Therapeutics in Q1 2024 and has held it in 4 quarters since.
  • 103 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Invesco's 13F filing for Q2 2026, filed 14 Aug 2026.